- About Us
- Our Programs
- Our Events
- uCity Square
- Support Us
February 26, 2019 | Philadelphia Business Journal
In another boost to Philadelphia’s standing as a cell and gene therapy hub, Cranbury, New Jersey-based Amicus Therapeutics said Tuesday it is establishing a new global research and gene therapy center at uCity Square, where the company expects to have 200 employees over the next few years.
Amicus will occupy the top three floors — a total of 75,000-square-foot — at the new University City Science Center building at 3675 Market Street. Its research center is expected to be completed during the second half of this year.